Pulmonary & Sleep Consultants

Personal and Professional Pulmonary & Sleep services in South Florida

  • Home
  • Services
    • Pulmonary Medicine
    • Obstructive Sleep Apnea (OSA)
    • Lung nodules
    • Weight Management
  • Our Team
    • J.J. Rajter MD
    • Juliana Cepelowicz Rajter, MD
  • Contact Us
  • Resources
    • Do you have OSA?
    • Instructions
    • Discount Coupons and Links
    • Medication Information
    • Post a review
    • Hospital Affiliations – Fort Lauderdale & South Florida
  • Blog
  • Store
    • CPAP Masks
    • CPAP Supplies
    • Pulmonary Supplies
    • Over The Counter Medications
    • Smoking Cessation
  • Patient Portal

Weight Management Options

Choosing the right weight management medication is a personal decision that depends on your health goals, lifestyle, and how comfortable you are with needles. As of 2026, there are several highly effective options, ranging from once-weekly injections to daily pills.

Here is a comparison of Zepbound, Wegovy (Injectable), Wegovy Pill, and the newest option, Foundayo.


Medication Comparison Table

Feature Zepbound Wegovy (Injectable)
Ozempic (Injectable)
Wegovy Pill Foundayo
Active Ingredient Tirzepatide Semaglutide Semaglutide Orforglipron
How it Works Mimics 2 hormones (GLP-1 & GIP) Mimics 1 hormone (GLP-1) Mimics 1 hormone (GLP-1) Mimics 1 hormone (GLP-1)
Form Weekly Injection Weekly Injection Daily Pill >Daily Pill
Avg. Weight Loss ~21% (High dose) ~15% ~15% ~12-13%
Food Restrictions None None Strict: Take 30 min before first meal/drink None: Take any time, with or without food
Storage Refrigerate Refrigerate Room Temperature Room Temperature

Breaking Down the Options

1. Zepbound (Injection)

Zepbound is currently the most potent option for weight loss. Because it mimics two different “fullness” hormones (GLP-1 and GIP), it often yields slightly higher results than the others.

  • Best for: Patients looking for the highest average weight loss and who don’t mind a once-weekly needle.
  • Unique Benefit: Also FDA-approved to treat moderate-to-severe Obstructive Sleep Apnea

2. Wegovy (Injection) / Ozempic (Injection)

The “gold standard” of GLP-1 therapy. It has a long track record and significant data regarding heart health.

  • Best for: Patients with a history of heart disease or high cardiovascular risk.
  • Unique Benefit: Proven to reduce the risk of <b”>major heart attacks and strokes in patients with established heart disease.

3. Wegovy Pill (Oral)

This is the tablet version of the Wegovy injection. It provides similar results to the shot but requires a very specific morning routine.

Best for: Patients who want Wegovy’s heart benefits but have a “needle phobia.”

  • The Catch: You must take it on an empty stomach with a tiny sip of water and wait at least 30 minutes before eating or drinking anything else. If you skip this, the medicine may not work.

4. Foundayo (Oral)

Approved in 2026, Foundayo is the first “non-peptide” GLP-1 pill. This makes it much more stable in your stomach.

  • Best for: Patients who want a pill but have an irregular schedule.
  • Unique Benefit: Unlike the Wegovy pill, Foundayo has no food or water restrictions. You can take it whenever is most convenient for you.

Common Side Effects & Safety

All four medications share a similar side-effect profile, primarily affecting the digestive system:

  • Nausea or vomiting
  • Diarrhea or constipation>
  • Stomach pain

Important Safety Note: All of these medications carry a “Boxed Warning” regarding thyroid C-cell tumors. They should not be used if you or your family have a history of Medullary Thyroid Carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).


Which one is right for you?

  • Prioritizing maximum weight loss? Look at Zepbound.
  • Concerned about heart health? Look at Wegovy (Injectable or Pill).
  • Hate needles and want maximum convenience? Look at Foundayo.

Does your daily routine make it easier to remember a once-weekly injection, or would a daily pill fit better into your morning habits?

Recent Posts

  • Dr. Rajter’s opening statement to US Senate Homeland Security Hearing on early treatment for COVID-19.
  • Multifaceted highly targeted sequential multidrug treatment of early ambulatory high-risk SARS-CoV-2 infection (COVID-19)
  • Chest Journal. Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019
  • Chest Journal Club Webinar. Icon Study: Use of Ivermectin in Hospitalized Patients With COVID-19.

Contact Info

Pulmonary and Sleep Consultants
1001 S. Andrews Ave
Suite 100
Fort Lauderdale, FL 33316

Tel. 954-906-6000
Fax. 954-860-7650

Copyright © 2026 Pulmonary and Sleep Consultants     ·     Built by MySalesButler.com, LLC